Medistim ASA
OSE:MEDI
Intrinsic Value
Medistim ASA engages in the development, manufacturing, and distribution of medical equipment and consumables. [ Read More ]
The intrinsic value of one MEDI stock under the Base Case scenario is 189.57 NOK. Compared to the current market price of 175 NOK, Medistim ASA is Undervalued by 8%.
Valuation Backtest
Medistim ASA
Run backtest to discover the historical profit from buying and selling MEDI stocks based on their intrinsic value.
Analyze the historical link between intrinsic value and market price to make more informed investment decisions.
Fundamental Analysis
Balance Sheet Decomposition
Medistim ASA
Current Assets | 414.2m |
Cash & Short-Term Investments | 170.3m |
Receivables | 86.6m |
Other Current Assets | 157.4m |
Non-Current Assets | 114.1m |
PP&E | 61.6m |
Intangibles | 48m |
Other Non-Current Assets | 4.5m |
Current Liabilities | 85.9m |
Other Current Liabilities | 85.9m |
Non-Current Liabilities | 12.6m |
Long-Term Debt | 9.1m |
Other Non-Current Liabilities | 3.5m |
Earnings Waterfall
Medistim ASA
Revenue
|
530.9m
NOK
|
Cost of Revenue
|
-111.4m
NOK
|
Gross Profit
|
419.5m
NOK
|
Operating Expenses
|
-289.5m
NOK
|
Operating Income
|
130.1m
NOK
|
Other Expenses
|
-27.5m
NOK
|
Net Income
|
102.5m
NOK
|
Free Cash Flow Analysis
Medistim ASA
MEDI Profitability Score
Profitability Due Diligence
Medistim ASA's profitability score is 72/100. The higher the profitability score, the more profitable the company is.
Score
Medistim ASA's profitability score is 72/100. The higher the profitability score, the more profitable the company is.
MEDI Solvency Score
Solvency Due Diligence
Medistim ASA's solvency score is 87/100. The higher the solvency score, the more solvent the company is.
Score
Medistim ASA's solvency score is 87/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
MEDI Price Targets Summary
Medistim ASA
According to Wall Street analysts, the average 1-year price target for MEDI is 193.8 NOK with a low forecast of 191.9 NOK and a high forecast of 199.5 NOK.
Shareholder Return
MEDI Price
Medistim ASA
Average Annual Return | 24.08% |
Standard Deviation of Annual Returns | 43.87% |
Max Drawdown | -55% |
Market Capitalization | 3.2B NOK |
Shares Outstanding | 18 269 000 |
Percentage of Shares Shorted |
N/A
|
Company Profile
Country
Industry
Market Cap
Dividend Yield
Description
Medistim ASA engages in the development, manufacturing, and distribution of medical equipment and consumables. The company is headquartered in Oslo, Oslo. The company went IPO on 2004-05-28. The company develops, manufactures and distributes medical devices primarily for cardiac and vascular surgery. The firm provides intra-operative standard control applications designed to verify and document quality during surgery. Its product portfolio comprises systems, such as ultrasound imaging systems VeriQ C and MiraQ, as well as probes, which offer Transit Time Flow Measurement (TTFM). The Company’s activities are divided into four business areas: lease of equipment within cardiac surgery, capital and consumable sales within cardiac surgery, sales of electronic stethoscopes and distribution and sales of third party products. Furthermore, the Company is a parent of Medistim USA Inc, Medistim Deutschland GmbH, and Medistim Norge AS, among others.
Officers
The intrinsic value of one MEDI stock under the Base Case scenario is 189.57 NOK.
Compared to the current market price of 175 NOK, Medistim ASA is Undervalued by 8%.